Skip to content

Evaluation of CRB in PROM Patients

Randomized Study to Compare the Cook Cervical Ripening Balloon (CRB) Plus Pitocin to Pitocin Alone in Premature Rupture of Membranes (PROM) Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01736852
Enrollment
129
Registered
2012-11-29
Start date
2012-11-30
Completion date
2018-12-31
Last updated
2020-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Rupture of Fetal Membranes

Keywords

Premature Rupture of Membrane (Pregnancy), PROM, Cervical Ripening, Induced Labor

Brief summary

The CRB study is designed to study the safety and effectiveness of the Cook Cervical Ripening Balloon (CRB) for the induction of labor in term and near-term patients with premature rupture of membranes (PROM).

Interventions

DEVICECRB

Labor induction using the CRB

Labor induction using Pitocin

Sponsors

Cook Group Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PROM not in labor

Exclusion criteria

* Contraindication to vaginal delivery * Contraindication to labor induction * Abnormal fetal heart-rate patterns * Maternal heart disease * Severe maternal hypertension * Pelvic structural abnormality

Design outcomes

Primary

MeasureTime frameDescription
Time of LaborStart of labor induction through delivery, an expected average of 6 hoursTime, in minutes, from the start of labor induction through delivery
Incidence of InfectionThrough hospital discharge, an expected average of 3 daysnumber of patients with chorioamnionitis

Countries

United States

Participant flow

Participants by arm

ArmCount
CRB Plus Pitocin
CRB: Labor induction using the CRB Pitocin: Labor induction using Pitocin
64
Pitocin
Pitocin: Labor induction using Pitocin
61
Total125

Baseline characteristics

CharacteristicCRB Plus PitocinPitocinTotal
Age, Continuous25.0 years
STANDARD_DEVIATION 5.1
26.3 years
STANDARD_DEVIATION 5.5
25.7 years
STANDARD_DEVIATION 5.3
Bishop score at time of enrollment4.4 units on a scale
STANDARD_DEVIATION 1.4
4.1 units on a scale
STANDARD_DEVIATION 1.4
4.2 units on a scale
STANDARD_DEVIATION 1.5
Gestational age (weeks/days)
34/0 - 36/6
12 Participants12 Participants24 Participants
Gestational age (weeks/days)
37/0 - 42/6
52 Participants49 Participants101 Participants
Multiple (2 or more) previous pregnancies31 Participants28 Participants59 Participants
Race/Ethnicity, Customized
Asian
3 Participants2 Participants5 Participants
Race/Ethnicity, Customized
Black
7 Participants6 Participants13 Participants
Race/Ethnicity, Customized
First Nation
5 Participants2 Participants7 Participants
Race/Ethnicity, Customized
Hispanic or Latino
29 Participants27 Participants56 Participants
Race/Ethnicity, Customized
Hispanic or Latino/White
2 Participants3 Participants5 Participants
Race/Ethnicity, Customized
White
18 Participants21 Participants39 Participants
Sex: Female, Male
Female
64 Participants61 Participants125 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 630 / 61
other
Total, other adverse events
27 / 6321 / 61
serious
Total, serious adverse events
5 / 634 / 61

Outcome results

Primary

Incidence of Infection

number of patients with chorioamnionitis

Time frame: Through hospital discharge, an expected average of 3 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CRB Plus PitocinIncidence of Infection7 Participants
PitocinIncidence of Infection6 Participants
Comparison: .ample size calculations were performed using an expected rate of 4% for each group,a one-sided exact test, α = 0.025, power = 0.80, non-inferiority margin of 10% resulting in a sample size of 124 patients or 62 patients per treatment arm.p-value: 0.06Fisher Exact
Primary

Time of Labor

Time, in minutes, from the start of labor induction through delivery

Time frame: Start of labor induction through delivery, an expected average of 6 hours

ArmMeasureValue (MEAN)Dispersion
CRB Plus PitocinTime of Labor850.4 MinutesStandard Deviation 417.6
PitocinTime of Labor1016.6 MinutesStandard Deviation 595.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026